Top

Published in:

01-10-2013 | Research

Predictors of Locoregional Recurrence in T1-2N0 Tongue Cancer Patients

Authors: Souichi Yanamoto, Shin-ichi Yamada, Hidenori Takahashi, Goro Kawasaki, Hisazumi Ikeda, Takeshi Shiraishi, Shuichi Fujita, Tohru Ikeda, Izumi Asahina, Masahiro Umeda

Published in: Pathology & Oncology Research | Issue 4/2013

Abstract

Locoregional recurrence of oral tongue squamous cell carcinoma (OTSCC) has been considered a poor prognostic entity in terms of survival rate. The purpose of this study was to evaluate the incidence of locoregional recurrence and to identify significant risk factors for locoregional recurrence in early-stage OTSCC. We retrospectively reviewed the records of 58 patients who underwent radical surgery for T1-2N0 OTSCC. The local recurrence and regional recurrence rates were 10.3 % (6/58 patients) and 15.5 % (9/58 patients) in this study, respectively. The survival rate of patients with local recurrence was 66.7 %, which was significantly lower than that (96.2 %) of patients without local recurrence, whereas the survival rates of patients with or without regional recurrence were not significantly difference. Pattern of invasion (POI), neoadjuvant chemotherapy (NAC) and the status of the surgical margin were identified as factors influencing local recurrence. In particular, the status of the deep surgical margin was a high potential independent risk factor. The deep surgical margin was resected closely in many NAC-treated cases, suggesting that NAC may lead to local recurrence and a poor outcome. No efficacy of NAC was observed, suggesting that the standard treatment for early OTSCC is surgery alone.

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global Cancer Statistics 2011. CA Cancer J Clin 61:69–90PubMedCrossRef

Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef

National Cancer Institute (2012). Surveillance, Epidemiology, and End Results (SEER) web site. http://seer.cancer.gov/statistics/. Accessed 15 March 2012

Rusthoven KE, Raben D, Song JI, Kane M, Altoos TA, Chen C (2010) Survival and patterns of relapse in patients with oral tongue cancer. J Oral Maxillofac Surg 68:584–589PubMedCrossRef

Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer 118:101–111PubMedCrossRef

Spiro RH, Guillamondegui O, Paulino AF, Huvos AG (1999) Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 21:408–413PubMedCrossRef

Goto M, Hasegawa Y, Terada A, Hyodo I, Hanai N, Ijichi K, Yamada H, Fujimoto Y, Ogawa T (2005) Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers. Oral Oncol 41:62–69PubMedCrossRef

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY (2005) Oral squamous cell carcinoma. Histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167–178PubMedCrossRef

Pentenero M, Gandolfo S, Carrozzo M (2005) Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma a review of the literature. Head Neck 27:1080–1091PubMedCrossRef

10.

Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, Bedrin L, Talmi YP, Taicher S (2010) Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136:1039–1048PubMedCrossRef

11.

El-Naaj IA, Leiser Y, Shveis M, Sabo E, Peled M (2011) Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg 69:2674–2679PubMedCrossRef

12.

Shah JP, Gil Z (2009) Current concepts in management of oral cancer. Oral Oncol 45:394–401PubMedCrossRef

13.

Brennan S, Corry J, Kleid S, Porceddu S, Yuen K, Rischin D, Peters LJ (2010) Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with ct-staged T1-2 N0 squamous cell carcinoma of the oral tongue. Head Neck 32:191–198PubMedCrossRef

14.

Nag S, Cano ER, Demanes J, Puthawala AA, Vikram B (2001) The American brachytherapy society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radia Oncol Biol Phys 50:1190–1198CrossRef

15.

Mazeron JJ, Ardiet JM, Haie-Meder C, Kovacs G, Levendag P, Peiffert D, Polo A, Rovirosa A, Strnad V (2009) GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 91:150–156PubMedCrossRef

16.

Umeda M, Komatsubara H, Ojima Y, Minamikawa T, Shibuya Y, Yokoo S, Ishii J, Komori T (2005) A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 34:739–744

17.

Sobin LH, Wittekind C (2002) UICC TNM classification of malignant tumours, 6th edn. Wiley, New York

18.

Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (eds) (1997) World Health Organization histological typing of cancer and precancer of the oral mucosa, 2nd edn. Springer, New York

19.

Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J, Bankfalvi A (1998) The invasive front of carcinomas. The most important area for tumor prognosis? Anticancer Res 18:4757–4764PubMed

20.

Asakage T, Yokose T, Mukai K, Tsugane S, Tsubono Y, Asai M, Ebihara S (1998) Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 82:1443–1448PubMedCrossRef

21.

Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, Takahashi T (2002) Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 24:731–736PubMedCrossRef

22.

Lim SC, Zhang S, Ishii G, Endoh Y, Kodama K, Miyamoto S, Hayashi R, Ebihara S, Cho JS, Ochiai A (2004) Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res 10:166–172PubMedCrossRef

23.

Sparano A, Weinstein G, Chalian A, Yodul M, Weber R (2004) Multivariate predictors of occult neck metastasis in early oral tongue cancer. Otolaryngol Head Neck Surg 131:472–476PubMedCrossRef

24.

Huang SH, Hwang D, Lockwood G, Goldstein DP, O’Sullivan B (2009) Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity. A meta-analysis of reported studies. Cancer 115:1489–1497PubMedCrossRef

25.

Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EYC, Chen IH, Liao CT, Chang JTC (2010) Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiation Oncology Biol Phys 77:1024–1029CrossRef

26.

Kernohan MD, Clark JR, Gao K, Ebrahimi A, Milross CG (2010) Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg 136:1235–1239PubMedCrossRef

27.

Huang TY, Hsu LP, Wen YH, Huang TT, Chou YF, Lee CF, Yang MC, Chang YK, Chen PR (2010) Predictors of locoregional recurrence in early stage oral cavity cancer with free surgical margins. Oral Oncol 45:49–55CrossRef

28.

O-charoenrat PO, Pillai G, Patel S, Fisher C, Archer D, Eccles S, Rhys-Evans P (2003) Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 39:386–390PubMedCrossRef

29.

Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, Al-Amro A (2000) Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 36:508–514PubMedCrossRef

30.

Yuen APW, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, Yuen WF, Wei WI (2002) Prognostic factors of clinically stage I and II oral tongue carcinoma-a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martines-Gimen score, and pathologic features. Head Neck 24:513–520PubMedCrossRef

31.

Keski-Säntti H, Atula T, Tikka J, Hollmén J, Mäkitie AA, Leivo I (2007) Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 43:1007–1013PubMedCrossRef

32.

Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355:949–955PubMed

33.

Kirita T, Ohgi K, Kawakami M, Miyawaki S, Okamoto M, Yamanaka Y, Sugimura M (2002) Primary tumour resection of tongue carcinoma based on response to preoperative therapy. Int J Oral Maxillofac Surg 31:267–272PubMedCrossRef

34.

Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R, Cantu G (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333PubMedCrossRef

35.

Olasz L, Szalma J, Orsi E, Tornoczky T, Marko T, Nyarady Z (2010) Neoadjuvant chemotherapy: does it have benefits for surgeon in the treatment of advanced squamous cell cancer of the oral cavity? Pathol Oncol Res 16:207–212PubMedCrossRef

36.

Lore JM, Diaz-Ordaz E, Spaulding M, Chary K, Kaufman S, Lawrence W, Hong F, Gerold T, Sundquist N, Barrali RA (1995) Improved survival with preoperative chemotherapy followed by tumor response for advanced squamous cell carcinoma of the head and neck. Am J Surg 170:506–511PubMedCrossRef

37.

Okura M, Hiranuma T, Adachi T, Ogura T, Aikawa T, Yoshioka H, Hayashido Y, Kogo M, Matsuya T (1998) Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer 82:804–815PubMedCrossRef

38.

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Michel B, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Eng J Med 350:1945–1952CrossRef

39.

Kurita H, Nakanishi Y, Nishizawa R, Xiao T, Kamata T, Koike T, Kobayashi H (2010) Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol 46:814–817PubMedCrossRef

40.

Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA (2003) The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 32:30–34PubMedCrossRef

41.

Upile T, Fisher C, Jerjes W, El Maaytah M, Searle A, Archer D, Michaels L, Rhys-Evans P, Hopper C, Howard D, Wright A (2007) The uncertainty of the surgical margin in the treatment of head and neck cancer. Oral Oncol 43:321–326PubMedCrossRef

42.

Umeda M, Shigeta T, Takahashi H, Minamikawa T, Komatsubara H, Oguni A, Shibuya Y, Komori T (2011) Cinical evaluation of Lugol’s iodine staining in the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 40:593–596PubMedCrossRef

43.

Kim JJ, Tannock IF (2005) Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5:516–525PubMedCrossRef

44.

Bourhis J, Wilson G, Wibault P, Janot F, Bosq J, Armand JP, Luboinski B, Malaise EP, Eschwege F (1994) Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer. Laryngoscope 104:468–472PubMedCrossRef

45.

Penel N, Fournier C, Lefebvre D, Roussel-Delvallez M, Sarini J, Kar A, Mallet Y, Lefebvre JL (2004) Previous chemotherapy as a predictor of wound infections in nonmajor head and neck surgery: results of a prospective study. Head Neck 26:513–517PubMedCrossRef

46.

Penel N, Fournier C, Lefebvre D, Lefebvre JL (2005) Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 41:294–303PubMedCrossRef

47.

Rahima B, Shingaki S, Nagata M, Saito C (2004) Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:423–431PubMedCrossRef

48.

Gonzalez-Garcia R, Naval-Gias L, Roman-Romero L, Sastre-Perez J, Rodriguez-Campo FJ (2009) Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: a retrospective analytic study of 500 patients. Head Neck 31:1168–1180PubMedCrossRef

49.

Ord RA, Kolokythas A, Reynolds MA (2006) Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg 64:1409–1414PubMedCrossRef

50.

Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG (2000) Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 22:34–41PubMedCrossRef

51.

Sklenicka S, Gardiner S, Dierks EJ, Potter BE, Bell RB (2010) Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: Does surgical salvage affect outcome? J Oral Maxillofac Surg 68:1270–1275PubMedCrossRef

52.

Kaya S, Yilmaz T, Gürsel B, Saraç S, Sennaroğlu L (2001) The value of elective neck dissection in treatment of cancer of the tongue. Am J Otolaryngol 22:59–64PubMedCrossRef

53.

Lim YC, Lee JS, Koo BS, Kim SH, Kim YH, Choi EC (2006) Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation. Laryngoscope 116:461–465PubMedCrossRef

Title: Predictors of Locoregional Recurrence in T1-2N0 Tongue Cancer Patients
Authors: Souichi Yanamoto
Shin-ichi Yamada
Hidenori Takahashi
Goro Kawasaki
Hisazumi Ikeda
Takeshi Shiraishi
Shuichi Fujita
Tohru Ikeda
Izumi Asahina
Masahiro Umeda
Publication date: 01-10-2013
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 4/2013
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-013-9646-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2013

Retrospective Analysis of Clinicopathological Characteristics and Family History Data of Early-Onset Breast Cancer: A Single-Institutional Study of Hungarian Patients

Large Cell Lymphoma: Correlation of HIV Status and Prognosis with Differentiation Profiles Assessed by Immunophenotyping

A Meta-Analysis of HIF-1α and Esophageal Squamous Cell Carcinoma (ESCC) Risk

Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Invasive Ductal Carcinoma of the Breast: The Impact on Prognosis and Correlation to Clinicopathologic Features

Tumor-Related Gene Changes in Immunosuppressive Syrian Hamster Cholangiocarcinoma

Clinicopathological Significance of L-type Amino Acid Transporter 1 (LAT1) Expression in Patients with Adenoid Cystic Carcinoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer